Regional Business Manager at Alamar Biosciences

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Bachelors degree in the Life Sciences or related field
5+ years or equivalent of proven life science capital sales experience and success
Deep knowledge of biomarker discovery and life science markets
Highly adaptable and independent professional
Strong desire to build customer relationships for long term engagement
Ideally Based in Chicago, Minneapolis, or Indianapolis

Responsibilities

Develop a territory and account-based sales plan for the territory
Execute the plan for the territory to meet or exceed company goals
Deliver presentations on the Alamar technology to customers in seminars and meetings
Consult customers on the value of Alamar technology for precision proteomics to ensure the delivery of an exceptional customer experience
Partner across the company to communicate the needs of customers to drive future product developments and market expansion
Manage and drive the sales process within a complex sales environment
Utilize, update and manage the CRM system
Effectively manage and deliver an accurate forecast for the sales territory
Drive prospecting and develop new leads in the region to expand the pipeline, customer base and open up new markets
Support the expansion of the commercial organization as needed to meet the company goals

Skills

Territory Management

Account-Based Selling

Sales Presentations

Customer Relationship Management

Commercial Strategy

Proteomics

Cross-Functional Collaboration

B2B Sales

Alamar Biosciences

Develops technology for protein detection and measurement

About Alamar Biosciences

Alamar Biosciences focuses on the study of proteins, known as proteomics, to enhance disease detection and treatment. The company has created NULISA™, a technology that can detect and measure proteins in the human body with high sensitivity and a wide range. This allows researchers and clinicians to profile clinically relevant protein biomarkers, which are essential for developing new diagnostic tests and treatments for various diseases. Alamar's ARGO™ system complements NULISA™ by providing a fully automated, high-throughput platform for precision proteomics. Unlike competitors, Alamar's technology simplifies the process, reducing the need for extensive technical expertise, making it more accessible to clients. The goal of Alamar Biosciences is to improve our understanding of proteins in health and disease, ultimately leading to better early detection and treatment options.

Hayward, CaliforniaHeadquarters

2018Year Founded

$225.7MTotal Funding

GRANTCompany Stage

Biotechnology, HealthcareIndustries

51-200Employees

Benefits

401(k) Company Match

401(k) Retirement Plan

Performance Bonus

Company Equity

Risks

Increased competition from Olink and SomaLogic may impact Alamar's market share.

Scaling production in Europe and APAC could strain resources and affect quality.

Regulatory hurdles in new regions may delay product launches and affect revenue.

Differentiation

Alamar's NULISA™ technology offers unprecedented sensitivity in protein detection.

The ARGO™ system automates high-throughput proteomics, reducing the need for technical expertise.

Alamar's focus on early disease detection sets it apart in the biotechnology field.

Upsides

ISO 13485:2016 certification boosts Alamar's credibility in the medical device industry.

European expansion with Milan headquarters enhances market reach and client service.

$10M investment accelerates Alzheimer's diagnostics development, strengthening Alamar's market position.

Land your dream remote job 3x faster with AI

Try Jobo Free